isolated limb perfusion

DRUG4 trials

Sponsors

University of Miami, National Cancer Institute (NCI), Memorial Sloan Kettering Cancer Center, Albert Einstein College of Medicine

Conditions

Basal Cell Carcinoma of the SkinEccrine Carcinoma of the SkinMelanoma (Skin)Recurrent Adult Soft Tissue SarcomaRecurrent MelanomaRecurrent Skin CancerSarcomaSquamous Cell Carcinoma of the Skin

Phase 2

Isolated Limb Infusion of Chemotherapy in Treating Patients With Melanoma or Soft Tissue Sarcoma of the Arm or Leg That Cannot Be Removed By Surgery

CompletedNCT00004250

Memorial Sloan Kettering Cancer CenterMelanoma (Skin), Sarcoma

Start: 1999-08-31Target: 35Updated: 2013-01-16

Combination Chemotherapy in Treating Patients With Soft Tissue Sarcoma

CompletedNCT00002492

University of MiamiSarcoma

Start: 1991-11-30End: 2000-02-29Updated: 2016-12-15

Phase 3

Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Locally Advanced Melanoma of the Arm or Leg

CompletedNCT00003789

National Cancer Institute (NCI)Recurrent Melanoma, Stage III Melanoma

Start: 1999-03-31Updated: 2013-07-16

Unknown Phase

Isolated Limb Perfusion With Melphalan in Treating Patients With Stage IIIB-IV Melanoma or Sarcoma

WithdrawnNCT02507076

Albert Einstein College of MedicineBasal Cell Carcinoma of the Skin, Eccrine Carcinoma of the Skin, Recurrent Adult Soft Tissue Sarcoma +8

Start: 2012-04-30End: 2014-07-31Updated: 2015-07-23

Related Papers

Isolated limb infusion with melphalan and dactinomycin for regional melanoma and soft-tissue sarcoma of the extremity: final report of a phase II clinical trial.

2009-04-0116 citations